MMB-CHMICA

MMB-CHMICA
Clinical data
Other names	AMB-CHMICA
Legal status
Legal status	CA: Schedule II; DE: NpSG (Industrial and scientific use only); UK: Under Psychoactive Substances Act; US: Schedule I;
Identifiers
	IUPAC name Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-L-valinate;
CAS Number	1971007-94-9 ;
ChemSpider	68896113;
UNII	HEN6ZCR7GD;
CompTox Dashboard (EPA)	DTXSID301009991 ;
Chemical and physical data
Formula	C22H30N2O3
Molar mass	370.493 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)[C@@H](C(=O)OC)NC(=O)c1cn(c2c1cccc2)CC3CCCCC3;
	InChI InChI=1S/C22H30N2O3/c1-15(2)20(22(26)27-3)23-21(25)18-14-24(13-16-9-5-4-6-10-16)19-12-8-7-11-17(18)19/h7-8,11-12,14-16,20H,4-6,9-10,13H2,1-3H3,(H,23,25)/t20-/m0/s1; Key:ROWZIXRLVUOMCJ-FQEVSTJZSA-N;

MMB-CHMICA (AMB-CHMICA) is a designer drug and synthetic cannabinoid.^[1]^[2]^[3] In 2018, it was the sixth-most common synthetic cannabinoid identified in drugs seized by the Drug Enforcement Administration.^[4]